Mechelen, Belgium; 18 November 2019; 22:01 CET; regulated information – Galapagos NV ((Euronext &, NASDAQ:GLPG) received a new transparency notification from Wellington Management Group LLP.
Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 13 November 2019 from Wellington Management Group LLP, who indicated that, following a disposal of ordinary shares, American Depository Receipts and equity swaps, the remaining 3,126,030 Galapagos shares and equivalent financial instruments held by its entirely-controlled subsidiary Wellington Management Company LLP represent 4.84% of the current 64,571,622 outstanding Galapagos shares and thus crossed below the 5% threshold of Galapagos' voting rights on 13 November 2019. The full transparency notification is available on the Galapagos website.
About Galapagos
Galapagos ((Euronext &, NASDAQ:GLPG) discovers and develops small molecule medicines with novel modes of action, three of which show promising patient results and are currently in late-stage development in multiple diseases. The company's pipeline comprises Phase 3 through to discovery programs in inflammation, fibrosis, osteoarthritis and other indications. Galapagos' ambition is to become a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines. More information at www.glpg.com.
Contacts
Investors: Media:
Elizabeth Goodwin Carmen Vroonen
VP IR Senior Director Communications
+1 781 460 1784 +32 473 824 874
Sofie Van Gijsel Evelyn Fox
Director IR Director Communications
+32 485 19 14 15 +31 6 53 591 999
ir@glpg.com communications@glpg.com
1 Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market
Attachment
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.